Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
Status:
Completed
Trial end date:
2018-02-09
Target enrollment:
Participant gender:
Summary
This clinical trial studies disulfiram in treating patients with glioblastoma multiforme
(GBM) who have completed radiation therapy with temozolomide. Disulfiram may block some of
the enzymes needed for tumor cell growth and improve clinical outcome in GBM patients.